GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Cash And Cash Equivalents

Changchun BCHT Biotechnology Co (SHSE:688276) Cash And Cash Equivalents : ¥392 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Cash And Cash Equivalents?

Changchun BCHT Biotechnology Co's quarterly cash and cash equivalents declined from Sep. 2023 (¥459.41 Mil) to Dec. 2023 (¥442.18 Mil) but then stayed the same from Dec. 2023 (¥442.18 Mil) to Mar. 2024 (¥392.48 Mil).

Changchun BCHT Biotechnology Co's annual cash and cash equivalents declined from Dec. 2021 (¥1,155.60 Mil) to Dec. 2022 (¥866.54 Mil) and declined from Dec. 2022 (¥866.54 Mil) to Dec. 2023 (¥442.18 Mil).


Changchun BCHT Biotechnology Co Cash And Cash Equivalents Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co Cash And Cash Equivalents Chart

Changchun BCHT Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial 272.80 309.63 1,155.60 866.54 442.18

Changchun BCHT Biotechnology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 793.55 572.47 459.41 442.18 392.48

Changchun BCHT Biotechnology Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Changchun BCHT Biotechnology Co  (SHSE:688276) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Changchun BCHT Biotechnology Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Changchun BCHT Biotechnology Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Traded in Other Exchanges
N/A
Address
No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012
Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.
Executives
Shi Nian Min Core technical personnel
Jiang Chun Lai Directors, senior managers, core technical personn
Zhu Chang Lin Core technical personnel
Wei Wei Senior management, core technical personnel
Yu Bing senior management
Liu Da Wei Senior management, core technical personnel
Meng Zhao Feng senior management
Zhang Zhe senior management
Kong Wei Directors, senior managers, core technical personn
Feng Da Qiang Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines